NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
Nevro Corp (NYSE: NVRO)
NVRO Technical Analysis
5
As on 9th Jun 2023 NVRO STOCK Price closed @ 22.62 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 56.05 & Strong Sell for SHORT-TERM with Stoploss of 75.40 we also expect STOCK to react on Following IMPORTANT LEVELS. |
NVROSTOCK Price
Open | 23.65 | Change | Price | % |
High | 23.87 | 1 Day | -0.98 | -4.15 |
Low | 22.41 | 1 Week | -4.94 | -17.92 |
Close | 22.62 | 1 Month | -7.70 | -25.40 |
Volume | 639700 | 1 Year | -62.58 | -73.45 |
52 Week High 92.06 | 52 Week Low 23.12 |
NYSE USA Most Active Stocks
DDR | 15.44 | -4.46% |
NIO | 7.73 | -0.77% |
TWTR | 53.70 | 0.66% |
CVNA | 19.07 | -21.30% |
BACA-U | 302.00 | 0.67% |
PLTR | 15.02 | -1.12% |
F | 13.74 | 1.18% |
CS | 0.89 | 1.14% |
RPAI | 13.15 | -3.17% |
AUY | 5.85 | -0.68% |
NYSE USA Top Gainers Stocks
NYSE USA Top Losers Stocks
NVRO Daily Charts |
NVRO Intraday Charts |
Whats New @ Bazaartrend |
NVRO Free Analysis |
|
NVRO Important Levels Intraday
RESISTANCE | 25.43 |
RESISTANCE | 24.53 |
RESISTANCE | 23.97 |
RESISTANCE | 23.42 |
SUPPORT | 21.82 |
SUPPORT | 21.27 |
SUPPORT | 20.71 |
SUPPORT | 19.81 |
NVRO Forecast May 2024
4th UP Forecast | 86.29 |
3rd UP Forecast | 65.87 |
2nd UP Forecast | 53.25 |
1st UP Forecast | 40.63 |
1st DOWN Forecast | 4.61 |
2nd DOWN Forecast | -8.01 |
3rd DOWN Forecast | -20.63 |
4th DOWN Forecast | -41.05 |
NVRO Weekly Forecast
4th UP Forecast | 45.57 |
3rd UP Forecast | 38.21 |
2nd UP Forecast | 33.66 |
1st UP Forecast | 29.11 |
1st DOWN Forecast | 16.13 |
2nd DOWN Forecast | 11.58 |
3rd DOWN Forecast | 7.03 |
4th DOWN Forecast | -0.33 |
NVRO Forecast2024
4th UP Forecast | 160.54 |
3rd UP Forecast | 116.31 |
2nd UP Forecast | 88.97 |
1st UP Forecast | 61.63 |
1st DOWN Forecast | -16.39 |
2nd DOWN Forecast | -43.73 |
3rd DOWN Forecast | -71.07 |
4th DOWN Forecast | -115.3 |
Nevro Corp ( NYSE USA Symbol : NVRO )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
NVRO Other Details
Segment | EQ | |
Market Capital | 4035704832.00 | |
Sector | Healthcare | |
Industry | Medical Devices | |
Offical website | > echo $website ; ?> |
NVRO Address
NVRO Latest News
NVRO Business Profile
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. In addition, the company provides HF10 Therapy, which delivers neuromodulation solutions for treating chronic pain based on available clinical evidence. It sells its products through its direct sales force, and a network of sales agents and independent distributors. The company was incorporated in 2006 and is headquartered in Redwood City, California. Address: 1800 Bridge Parkway, Redwood City, CA, United States, 94065
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service